Consultation on insurance issues and training needed to improve the use of continuous glucose monitoring in primary care

NewsGuard 100/100 Score

Continuous glucose monitoring (CGM) is associated with improved health outcomes for patients with diabetes. Primary care practices, however, have been slow to adopt the technology.

Researchers used a web-based survey to assess CGM prescribing behaviors and resource needs of U.S. primary care clinicians. They found that clinicians located more than 40 miles from the nearest endocrinologist's office (endocrinologists being more specialized in treating diabetes) were more likely to have prescribed CGM and to have more favorable attitudes toward prescribing the devices in the future compared to clinicians located within 10 miles of an endocrinologist. Clinicians who served more Medicare patients reported more favorable attitudes toward future prescribing and higher confidence in using CGM to manage diabetes than those with fewer Medicare patients.

The authors assert that primary care doctors would benefit from consultation on insurance issues and CGM training to best support prescribing CGMs to their patients. The authors also advocate for continued expansion of Medicare and Medicaid coverage for CGMs.

Source:
Journal reference:

Oser, T.K., et al. (2022) Continuous Glucose Monitoring in Primary Care: Understanding and Supporting Clinicians’ Use to Enhance Diabetes Care. The Annals of Family Medicine. doi.org/10.1370/afm.2876.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Managing diabetes with probiotics and synbiotics